Mammoth Biosciences wins DARPA subcontract for CRISPR diagnostics

Mammoth Biosciences secured a subcontract with MRIGlobal for the DARPA DIGET program to develop CRISPR-based diagnostics and biosurveillance platforms for the U.S. Department of Defense.

“Mammoth Biosciences, Inc. today announced that it has secured a subcontract with MRIGlobal, the prime contractor with the Defense Advanced Research Projects Agency (DARPA), to develop CRISPR-based diagnostics and biosurveillance technologies for the U.S. Department of Defense.”webwire.com

• 1 source
• webwire.comMammoth Biosciences Secures Award to Develop CRISPR-based Diagnostics and Biosurveillance Platforms | WebWireKathryn RyanJan 14, 2021

Summarized from public sources; check the original articles before acting on it.